Researchers at the University of Louisville are studying Yersinia pestis, the bacteria that causes bubonic and pneumonic plague, to understand its capacity to evade the immune system. The immune system’s first responders, neutrophils, summon aid by emitting molecules called Leukotriene B4 (LTB4), but Yersinia pestis can block these signals. The study has received a $2.9m grant from the National Institutes of Health. A doctoral student also received a $100k grant from the NIH to research how Yersinia pestis changes vesicles produced by immune cells.
Looking At the Year Ahead: What Can We Expect Within the Cybersecurity Landscape?
In 2024, healthcare organisations experienced significant disruptions due to numerous data breaches and ransomware attacks. This impacted daily operations and caused financial hardship for some.
